dGenThera

Biotechnology Research • Durham, North Carolina, United States • 1-10 Employees

Company overview

Headquarters	Durham, North Carolina, United States
Website	dgenthera.com
NAICS	541714
Founded	2023
Employees	1-10

Key Contact at dGenThera

Anthony Casarez

Co-founder and CSO

About dGenThera

dGenThera is a next-generation targeted radiotherapeutics company advancing a differentiated pipeline of theranostic agents optimized for safety, scalability, and precision oncology. dGenThera’s proprietary chemistry enables exquisitely matched theranostic pairs—leveraging Astatine-211 (211At), Iodine-131 (131I), and Fluorine-18 (18F)—with engineered stable carbon-halogen bonds to drive accurate dosimetry, improve patient stratification, and reduce off-target toxicity.

dGenThera revenue & valuation

Annual revenue	$256,665
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$821,328
Total funding	No funding

Employees by Management Level

Total employees: 1-10

Seniority

Employees

C-Suite

Employees by Department

dGenThera has 1 employees across 1 departments.

Departments

Number of employees

Funding Data

dGenThera has never raised funding before.

Frequently asked questions

dGenThera is located in Durham, North Carolina, US.

dGenThera was founded in 2023, making it 3 years old. The company has established itself as a significant player in its industry over this time.

dGenThera has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.

Key Contact at dGenThera

Anthony Casarez

Co-founder and CSO

4.8

40,000 users